about
Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroidLong-acting beta2-agonists for stable chronic asthmaInhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatmentAdverse effects of beta-agonists: are they clinically relevant?Safety of long-acting beta2-agonists in the treatment of asthma.Time trends in acute childhood asthma in Basque Country, Spain.Regulation of interleukin-8 binding and function by heparin and alpha2-macroglobulin.
P2860
Q24246441-DCCE460A-241C-4182-A629-5E0D6E85229FQ24247926-D200E42E-C35A-4B6F-A927-1A02EDCA5F9AQ24250226-0F3DEC59-DF71-42CA-BDAE-C4B1CDB5DF47Q35627643-CB29B622-9DDA-4A9D-861C-B8172271E4BFQ37362572-DB69B4EB-E828-4AF0-8816-0E7268EE1FFDQ44160640-EE29038D-09FC-45AD-985B-988C3C33C4FFQ47914730-09870DCA-751E-42EB-909E-B63B10D1F04F
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
An explanation of the asthma paradox.
@en
type
label
An explanation of the asthma paradox.
@en
prefLabel
An explanation of the asthma paradox.
@en
P2860
P356
P1476
An explanation of the asthma paradox.
@en
P2093
P2860
P304
P356
10.1164/AJRCCM/147.6_PT_2.S29
P433
P577
1993-06-01T00:00:00Z